CymaBay Therapeutics, Inc.

VANGUARD GROUP INC

Report date

12/31/2023

Quarter

2023 Q4

Filed

3/11/2024

Shares

6,306,149

Value ($000)

148,951

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	3/11/2024	148,951	0.0%	6,306,149	12/31/2023
2023 Q3	12/18/2023	85,697	0.0%	5,747,587	9/30/2023
2023 Q2	8/14/2023	56,380	0.0%	5,148,880	6/30/2023
2023 Q1	7/14/2023	38,801	0.0%	4,449,608	3/31/2023
2022 Q4	2/10/2023	23,044	0.0%	3,675,298	12/31/2022
2022 Q3	11/14/2022	12,828	0.0%	3,665,062	9/30/2022
2022 Q2	8/12/2022	10,493	0.0%	3,557,042	6/30/2022
2022 Q1	5/13/2022	11,950	0.0%	3,842,376	3/31/2022
2021 Q4	2/14/2022	12,805	0.0%	3,788,457	12/31/2021
2021 Q3	11/12/2021	12,211	0.0%	3,345,308	9/30/2021
2021 Q2	8/13/2021	14,505	0.0%	3,326,782	6/30/2021
2021 Q1	5/14/2021	16,773	0.0%	3,694,418	3/31/2021
2020 Q4	2/12/2021	19,670	0.0%	3,427,011	12/31/2020
2020 Q3	11/16/2020	24,422	0.0%	3,373,119	9/30/2020
2020 Q2	8/14/2020	11,798	0.0%	3,380,750	6/30/2020
2020 Q1	5/15/2020	5,462	0.0%	3,689,840	3/31/2020
2019 Q4	2/14/2020	7,235	0.0%	3,691,325	12/31/2019